Intercept Pharmaceuticals Inc (ICPT) Return on Assets ROA from the third quarter of 2023 to third quarter of 2022 and for the year 2023, Average High and Low, Fundamental Ratios from Sep 30 2023 to Sep 30 2022 - CSIMarket
CSIMarket
 


Intercept Pharmaceuticals inc   (NASDAQ: ICPT)


Intercept Pharmaceuticals Inc 's ROA from the third quarter of 2023 to the third quarter of 2022 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Intercept Pharmaceuticals Inc 's ROA in the third quarter of 2023?
Intercept Pharmaceuticals Inc recorded a cumulative net loss of $-62 million during 12 months ending in the third quarter of 2023, resulting in a negative return on assets (ROA) of -12.76%.

However, within the Healthcare sector 318 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the second quarter of 2023 from 98 to 3640.

What is ROA?



Return On Assets (Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Total Assets Change -29.8 % -2.82 % 1.34 % -1.35 % 8.1 %
Y / Y Net Income Change - - - - -
Net Income (TTM) in million -62 209 207 222 206
Return On Assets (TTM) -12.76 % 39.79 % 39.21 % 42.15 % 39.08 %
ICPT's Total Ranking # 3640 # 98 # 106 # 98 # 119
Total Assets (TTM) in million 392 483 503 553 558
Seq. Total Assets Change -18.92 % -3.92 % -8.98 % -1 % 12.24 %
Seq. Net Income Change - - - - -



Return On Assets Company Ranking
Within: No.
Industry # 119
Sector # 319
Overall # 3580

Return On Assets Statistics
High Average Low
41.95 %
-47.8 %
-205.05 %
(Dec 31 2022)   (Mar 31 2014)





Financial Statements
Intercept Pharmaceuticals Inc 's Assets $ 392 million ICPT's Balance sheet
Intercept Pharmaceuticals Inc 's Income $ -3 million Quarterly ICPT's Income Statement
ICPT's Income by Division See ICPT's Income by Division



Annual Return On Assets (Dec 31 2022)
FY 2022
(Dec 31 2021)
FY 2021
(Dec 31 2020)
FY 2020
(Dec 31 2019)
FY 2019
(Dec 31 2018)
FY 2018
Y / Y Total Assets Change 4.87 % -8.09 % -23.32 % 49.58 % 6.83 %
Total Assets in million 553 527 573 748 500
Y / Y Net Income Change - - - - -
Net Income in million 222 -91 -275 -345 -309
Annual Return On Assets 40.13 % -17.35 % -47.94 % -46.09 % -61.86 %




Comment on ICPT's ROA in the fiscal year ending 2022
In the fiscal year 2022 ROA improved to 40.13 % compared to prior year, due to annual net income growth of % to $221.82 million, while value of Intercept Pharmaceuticals Inc 's overall assets grew just by 4.87 % to $552.70 million, compared to $552.70 a year before.


More Return On Assets Ratios
ICPT's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
ICPT's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for ICPT's Competitors
Subscribers only: Roa for Intercept Pharmaceuticals Inc 's Suppliers
Subscribers only: Return On Assets for ICPT's Customers

You may also want to know
ICPT's Roi ICPT's Inventory Turnover Ratio ICPT's Growth Rates ICPT's Dividend Comparisons
ICPT's Profitability Ratios ICPT's Asset Turnover Ratio ICPT's Dividend Growth
ICPT's Roe ICPT's Valuation Ratios ICPT's Financial Strength Ratios ICPT's Dividend Payout Ratio



Companies with similar Return On Assets at Sep 30 2023, within Healthcare Sector ROA


Date modified: 2026-09-08T15:11:05+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.